Adlai Nortye Ltd Asset Turnover Ratio (ANL), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Adlai Nortye Ltd  (ANL)
 

Adlai Nortye Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Adlai Nortye Ltd asset turnover ratio, the ability of Adlai Nortye Ltd's assets to generate revenue in the fourth quarter 2025, increased sequentially to 0.19 in the fourth quarter (Dec 31 2025), a new company high.

Within sector 157 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from to 3138.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ANL Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Asset Change -45.07 % -80.16 % -73.55 % -73.55 % -51.85 %
Y / Y Revenue Change 29.44 % - - - -
Asset Turnover Ratio (TTM) 0.19 - - - 0.04
ANL's Total Ranking # 3138 # # # #
Seq. Asset Change 0 % 0 % 0 % -45.07 % -63.87 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 158
Healthcare Sector # 459
Overall Market # 3138

Asset Turnover Ratio Statistics
High Average Low
0.19 0.11 0.04
(Dec 31 2025)   (Dec 31 2023)




ANL Company Profile • Back to ANL Efficiency Comparisons • Compare ANL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Urogen Pharma Ltd   0.52 $ 108.630  Millions$ 210.459  Millions
Bridgebio Pharma Inc   0.52 $ 502.076  Millions$ 974.026  Millions
Bristol myers Squibb Company  0.52 $ 48,194.000  Millions$ 93,507.500  Millions
Astrazeneca Plc  0.51 $ 58,739.000  Millions$ 114,074.000  Millions
Supernus Pharmaceuticals inc   0.51 $ 718.952  Millions$ 1,400.524  Millions
Gilead Sciences Inc   0.51 $ 29,443.000  Millions$ 57,427.750  Millions
Pacira Biosciences inc   0.51 $ 726.411  Millions$ 1,421.606  Millions
Novartis Ag  0.51 $ 56,674.000  Millions$ 110,949.000  Millions
Pacific Health Care Organization Inc  0.51 $ 6.715  Millions$ 13.182  Millions
Intuitive Surgical Inc   0.51 $ 10,064.300  Millions$ 19,798.525  Millions
Icon Plc  0.51 $ 8,251.340  Millions$ 16,269.782  Millions
Ultragenyx Pharmaceutical Inc   0.50 $ 673.000  Millions$ 1,335.159  Millions
Logicmark Inc  0.50 $ 11.426  Millions$ 22.837  Millions
Aytu Biopharma Inc  0.50 $ 61.870  Millions$ 123.842  Millions
Cryo cell International Inc   0.50 $ 31.566  Millions$ 63.429  Millions
Aurinia Pharmaceuticals Inc   0.50 $ 283.055  Millions$ 571.632  Millions
Enovis Corp  0.49 $ 2,245.597  Millions$ 4,541.134  Millions
Vertex Pharmaceuticals Inc  0.49 $ 12,001.300  Millions$ 24,355.625  Millions
Fonar Corporation  0.49 $ 106.031  Millions$ 216.852  Millions
Xenetic Biosciences Inc   0.48 $ 2.976  Millions$ 6.144  Millions
Cvrx inc   0.48 $ 56.340  Millions$ 116.318  Millions
Envista Holdings Corporation  0.48 $ 2,718.700  Millions$ 5,613.075  Millions
Ge Healthcare Technologies Inc   0.48 $ 17,190.000  Millions$ 35,529.750  Millions
Johnson and Johnson  0.48 $ 94,193.000  Millions$ 194,771.500  Millions
Inmode Ltd   0.48 $ 370.495  Millions$ 766.429  Millions
Nanobiotix S a   0.48 $ 36.504  Millions$ 75.891  Millions
Collegium Pharmaceutical Inc   0.48 $ 779.328  Millions$ 1,622.045  Millions
Boston Scientific Corporation  0.48 $ 20,075.000  Millions$ 42,019.750  Millions
Orthopediatrics Corp  0.48 $ 235.661  Millions$ 493.993  Millions
Kamada Ltd   0.48 $ 180.460  Millions$ 378.710  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.